期刊文献+

肝细胞癌组织中IMP3蛋白的表达及意义 被引量:14

下载PDF
导出
摘要 目的探讨胰岛素样生长因子ⅡmRNA结合蛋白3(insulin-like growth factorⅡmRNA binding protein 3I,MP3)在肝细胞癌(hepatocellular carcinoma,HCC)组织中的表达及临床病理意义。方法采用免疫组化SP法检测IMP3蛋白在92例HCC及58例癌旁肝组织中的表达,并比较临床病理特征及Ki-67的表达。应用统计学方法对结果进行分析。结果 HCC组织中IMP3蛋白表达的阳性率(70.7%)明显高于癌旁组织(2.2%,P=0.000)。IMP3的表达与肝癌组织分化程度、是否转移、AJCC分期及Ki-67表达有关(P值分别为0.0030、.0310、.005和0.002),与患者的年龄、性别、肿瘤大小等参数无关。结论 IMP3在HCC组织中的表达明显高于非癌肝组织,可作为HCC细胞预后及增生程度的潜在临床病理标记。
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第1期87-89,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(30960120) 吉林省科技厅科技发展计划(20095203)
  • 相关文献

参考文献3

二级参考文献22

  • 1吕自力,文剑明,罗殿中,张文敏,肖刚,张萌.肿瘤相关基因在肝细胞癌及癌旁正常肝组织中表达[J].临床与实验病理学杂志,2004,20(6):654-658. 被引量:4
  • 2Reis-Filho J S,Tutt A N.Triple negative tumours:a critical review[J].Histopathology,2008,52(1):108-18.
  • 3Cleator S,Heller W,Coombes R C.TriplE-negative breast cancer:therapeutic options[J].Lancet Oncol,2007,8(3):235-44.
  • 4Nielsen J,Christiansen J,LykkE-Andersen J,et al.A family of insulin-like growth factor Ⅱ mRNA-binding proteins represses translation in late development[J].Mol Cell Biol,1999,19(2):1262-70.
  • 5Sitnikova L,Mendese G,Liu Q,et al.IMP3 predicts aggressive superficial urothelial carcinoma of the bladder[J].Clin Cancer Res,2008,14(6):1701-6.
  • 6Jeng Y M,Chang C C,Hu F C,et al.RNA-binding protein insulin-like growth factor Ⅱ mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma[J].Hepatology,2008,48(4):1118-27.
  • 7Mueller-Pillasch F,Lacher U,Wallrapp C,et al.Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein[J].Oncogene,1997,14(22):2729-33.
  • 8Liao B,Hu Y,Herrick D J,et al.The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor Ⅱ leader-3 mRNA during proliferation of human K562 leukemia cells[J].J Biol Chem,2005,280(18):18517-24.
  • 9Vikesaa J,Hansen T V,Jonson L,et al.RNA-binding IMPs promote cell adhesion and invadopodia formation[J].EMBO J,2006,25(7):1456-68.
  • 10Jiang Z.Prognostic biomarkers in renal cell carcinoma[J].Expert Rev Mol Diagn,2007,7(3):293-307.

共引文献35

同被引文献101

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2于冬梅,阎晓初,郭德玉,柳凤轩,刘丽梅.VEGF和nm23蛋白在膀胱移行细胞癌中表达及临床意义[J].第三军医大学学报,2006,28(21):2180-2182. 被引量:16
  • 3黄文斌(摘译.IMP3是宫颈原位腺癌一个新的标记物[J].临床与实验病理学杂志,2007,23(4):411-411. 被引量:25
  • 4Lochhead P, Imamura Y, Morikawa T, et al. Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colo- rectal cancer[J]. Euro J Cancer,2012,48(18) :3405-3413.
  • 5Jiang Z,Chu PG, Woda BA, et al. Analysis of RNA-bind- ing protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma:a retrospective study[J]. Lancet On- col, 2006,7 (7) : 556-564.
  • 6Lu D,Vohra P,Chu PG,et al. An oncofetal protein IMP3 : a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia[J]. Amer J Surg Pathol, 2009,33 (4) : 521-525.
  • 7Findeis-Hosey JJ, Xu H. Insulin-like growth factor Ⅱ-mes- senger RNA-binding protein-3 and lung cancer[J]. Biotech Histoehem, 2012,87 ( 1 ) : 24-29.
  • 8Cornejo K, Shi M, Jiang Z. Oncofetal protein IMP3 : a useful diagnostic biomarker for leiomyosarcoma[J]. Hum Pathol, 2012,43(10) : 1567-1572.
  • 9Prince SN, Foulstone EJ, Zaccheo OJ, et al. Functional evalua- tion of novel soluble insulin-like growth factor (IGF)-Ⅱ- specific ligand traps based on modified domain 11 of the human IGF2 receptor[J]. Molecular Cancer Therapeutics, 2007,6(2) :607-617.
  • 10Findeis-Hosey JJ, Yang Q. IMP3 expression is correlated with histologic grade of lung adenocarcinoma[J]. Hum Pathol, 2010,41 (4) : 477-484.

引证文献14

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部